tradingkey.logo
tradingkey.logo
Suchen

GeneDx Holdings Corp

WGSWW
Zur Watchlist hinzufügen
0.004USD
-0.000-5.26%
Handelsschluss 07/02, 13:00ETKurse um 15 Minuten verzögert
0.00Marktkapitalisierung
--KGV TTM

mehr Informationen über GeneDx Holdings Corp Unternehmen

GeneDx Holdings Corp. is a genomics company. The Company is focused on delivering personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The Company's segments are GeneDx inclusive of Legacy GeneDx and Legacy Sema4. The GeneDx segment primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. GeneDx utilizes an integrated portfolio of laboratory processes, software tools, and informatics capabilities to process deoxyribonucleic acid (DNA)-containing samples, analyze information about patient-specific genetic variation and generate test reports for clinicians and their patients. GeneDx provides a variety of genetic diagnostic tests, screening solutions, and information. The Legacy Sema4 diagnostics segment provides reproductive and women's health and somatic oncology diagnostic testing and screening products.

GeneDx Holdings Corp Informationen

BörsenkürzelWGSWW
Name des UnternehmensGeneDx Holdings Corp
IPO-datumSep 04, 2020
CEOMs. Katherine A. Stueland
Anzahl der mitarbeiter- -
WertpapierartCompany Warrant
Geschäftsjahresende- -
Addresse333 Ludlow Street
StadtSTAMFORD
BörseNASDAQ Global Select Consolidated
LandUnited States of America
Postleitzahl06902
Telefon18887291206
Websitehttps://sema4.com/
BörsenkürzelWGSWW
IPO-datumSep 04, 2020
CEOMs. Katherine A. Stueland

Führungskräfte von GeneDx Holdings Corp

Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Thomas Fuchs
Dr. Thomas Fuchs
Director
Director
--
--
Mr. Jason Michael Ryan, CPA
Mr. Jason Michael Ryan, CPA
Chairman of the Board
Chairman of the Board
--
--
Mr. Keith A. Meister
Mr. Keith A. Meister
Independent Director
Independent Director
--
--
Mr. Joshua Ruch
Mr. Joshua Ruch
Independent Director
Independent Director
--
--
Ms. Katherine A. Stueland
Ms. Katherine A. Stueland
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Independent Director
Independent Director
--
--
Dr. Bryan Dechairo
Dr. Bryan Dechairo
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Kevin Feeley
Mr. Kevin Feeley
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Richard C. (Rick) Pfenniger, Jr.
Mr. Richard C. (Rick) Pfenniger, Jr.
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Thomas Fuchs
Dr. Thomas Fuchs
Director
Director
--
--
Mr. Jason Michael Ryan, CPA
Mr. Jason Michael Ryan, CPA
Chairman of the Board
Chairman of the Board
--
--
Mr. Keith A. Meister
Mr. Keith A. Meister
Independent Director
Independent Director
--
--
Mr. Joshua Ruch
Mr. Joshua Ruch
Independent Director
Independent Director
--
--
Ms. Katherine A. Stueland
Ms. Katherine A. Stueland
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von GeneDx Holdings Corp?

Die fünf größten Anteilseigner von GeneDx Holdings Corp sind: Dr. Thomas Fuchs